Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 10.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 29.80p
  • 52 Week Low: 8.70p
  • Currency: UK Pounds
  • Shares Issued: 687.01m
  • Volume: 1,341,742
  • Market Cap: £68.70m
  • Beta: 0.00

Latest ShareCast News

hVIVO secures largest standalone lab contract to date

By Josh White

Date: Tuesday 21 Jan 2025

(Sharecast News) - hVIVO announced on Tuesday that it has secured its largest standalone laboratory contract to date, with its hLAB division signing a £2.7m deal with a US-based biotechnology client, bringing the total value of the project to £3.2m.

hVIVO manufactures human challenge agent for Omicron

By Josh White

Date: Thursday 16 Mar 2023

(Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Thursday.

Open Orphan signs £10.4m contract with global pharma client

By Josh White

Date: Monday 22 Aug 2022

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £10.4m contract with an existing, unnamed top-five global pharmaceutical client to manufacture a new batch of H1N1 flu challenge virus, and to conduct a human challenge trial to test the client's antiviral product.

Open Orphan wins £7.2m contract for RSV human st... 14-Jun-2022 ShareCast
Open Orphan wins £7.3m human flu study contract 18-May-2022 ShareCast
Open Orphan wins £5m contract for human study in... 25-Mar-2022 ShareCast
Open Orphan appoints Mo Khan as its new chief ex... 24-Feb-2022 ShareCast
Open Orphan launches project collecting viral st... 14-Feb-2022 ShareCast
Open Orphan reports on world's first Covid-19 ch... 02-Feb-2022 ShareCast
Open Orphan signs £5m human flu study contract 21-Dec-2021 ShareCast
Open Orphan signs contract to test antiviral can... 10-Dec-2021 ShareCast
Open Orphan subsidiary locks in £5.1m contract w... 17-Nov-2021 ShareCast
Open Orphan subsidiary secures contract renewal ... 15-Nov-2021 ShareCast
Open Orphan signs £5.7m contract with biotech sp... 20-Sep-2021 ShareCast
Open Orphan secures €900,000 contract with... 14-Jul-2021 ShareCast
Open Orphan subsidiary scores 'significant contr... 09-Jul-2021 ShareCast
Cathal Friel-led Poolbeg Pharma set to float on ... 17-Jun-2021 ShareCast
Open Orphan subsidiary signs contract to make Co... 10-May-2021 ShareCast
Open Orphan makes progress with Covid-19 charact... 25-Mar-2021 ShareCast
Open Orphan subsidiary awarded contract with Oxf... 09-Mar-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 10.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 29.80p
52 Week Low 8.70p
Volume 1,341,742
Shares Issued 687.01m
Market Cap £68.70m
Beta 0.00

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
Price Trend
83.6% below the market average83.6% below the market average83.6% below the market average83.6% below the market average83.6% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average
Income
10.89% below the market average10.89% below the market average10.89% below the market average10.89% below the market average10.89% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
72.90% above the market average72.90% above the market average72.90% above the market average72.90% above the market average72.90% above the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

What The Brokers Say

Strong Buy 1
Buy 4
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 18-Apr-24
Paid 11-Jun-25 20-May-24
Amount 0.20p 0.20p

Trades for 28-Aug-2025

Time Volume / Share Price
16:35 30,000 @ 10.00p
16:35 29,576 @ 10.00p
16:35 424 @ 10.00p
16:25 2,151 @ 9.60p
16:14 100,000 @ 9.91p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page